KR20090092267A - 알레르기의 예방과 치료를 위한 약제의 제조에서 티모신 알파 1의 용도 - Google Patents

알레르기의 예방과 치료를 위한 약제의 제조에서 티모신 알파 1의 용도

Info

Publication number
KR20090092267A
KR20090092267A KR1020097008098A KR20097008098A KR20090092267A KR 20090092267 A KR20090092267 A KR 20090092267A KR 1020097008098 A KR1020097008098 A KR 1020097008098A KR 20097008098 A KR20097008098 A KR 20097008098A KR 20090092267 A KR20090092267 A KR 20090092267A
Authority
KR
South Korea
Prior art keywords
treatment
thymosin alpha
allergies
prevention
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020097008098A
Other languages
English (en)
Korean (ko)
Inventor
루이지나 로마니
프란세스코 비스토니
엔리코 가라씨
구이도 라시
파올라 시니발디 발레보나
Original Assignee
시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. filed Critical 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이.
Publication of KR20090092267A publication Critical patent/KR20090092267A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020097008098A 2006-10-27 2007-09-27 알레르기의 예방과 치료를 위한 약제의 제조에서 티모신 알파 1의 용도 Withdrawn KR20090092267A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000583A ITRM20060583A1 (it) 2006-10-27 2006-10-27 Uso della timosina alfa 1 per la preparazione di un medicamento per la prevenzione e la cura delle allergie
ITRM2006A000583 2006-10-27

Publications (1)

Publication Number Publication Date
KR20090092267A true KR20090092267A (ko) 2009-08-31

Family

ID=39322638

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097008098A Withdrawn KR20090092267A (ko) 2006-10-27 2007-09-27 알레르기의 예방과 치료를 위한 약제의 제조에서 티모신 알파 1의 용도

Country Status (13)

Country Link
US (1) US20090270594A1 (https=)
EP (1) EP2083847A2 (https=)
JP (1) JP2010507649A (https=)
KR (1) KR20090092267A (https=)
CN (1) CN101626778A (https=)
AU (1) AU2007310415A1 (https=)
BR (1) BRPI0718019A2 (https=)
CA (1) CA2666562A1 (https=)
EA (1) EA200900603A1 (https=)
IL (1) IL198290A0 (https=)
IT (1) ITRM20060583A1 (https=)
MX (1) MX2009004237A (https=)
WO (1) WO2008050362A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
AR020102A1 (es) * 1998-07-30 2002-04-10 Ucb Sa Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento
US20060121029A1 (en) * 2002-08-30 2006-06-08 Hiroshi Shiku Method and composition for regulating the activity of regulatory t cells
DK1613340T3 (da) * 2003-03-28 2010-08-30 Sciclone Pharmaceuticals Inc Behandling af aspergillus-infektioner med thymosin alfa 1

Also Published As

Publication number Publication date
CA2666562A1 (en) 2008-05-02
WO2008050362A3 (en) 2008-07-10
EP2083847A2 (en) 2009-08-05
ITRM20060583A1 (it) 2008-04-28
EA200900603A1 (ru) 2009-10-30
AU2007310415A1 (en) 2008-05-02
MX2009004237A (es) 2009-07-07
BRPI0718019A2 (pt) 2013-11-19
JP2010507649A (ja) 2010-03-11
CN101626778A (zh) 2010-01-13
US20090270594A1 (en) 2009-10-29
IL198290A0 (en) 2011-08-01
WO2008050362A2 (en) 2008-05-02

Similar Documents

Publication Publication Date Title
Maruszewska-Cheruiyot et al. Helminth therapy: advances in the use of parasitic worms against inflammatory bowel diseases and its challenges
US20230063416A1 (en) Polytherapy Modulating Cathelicidin Gene Expression Modulation for The Treatment of Alzheimer's Disease and Other Conditions
JP6359013B2 (ja) １，５−ｄ−アンヒドロフルクトースを含むアポトーシス関連スペック様カード蛋白質の機能阻害薬
Chen et al. 3-Hydroxybenzaldehyde and 4-Hydroxybenzaldehyde enhance survival of mouse astrocytes treated with Angiostrongylus cantonensis young adults excretory/secretory products
He et al. Patchouli alcohol ameliorates depression-like behaviors through inhibiting NLRP3-mediated neuroinflammation in male stress-exposed mice
Singh et al. A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of bioactive peptides
Miao et al. The neuroprotective effects and transdifferentiation of astrocytes into dopaminergic neurons of Ginkgolide K on Parkinson’disease mice
WO2013180240A1 (ja) 全身麻酔薬と、水素とを組み合わせてなる、医薬
Wang et al. From the immune system to mood disorders especially induced by Toxoplasma gondii: CD4+ T cell as a bridge
CN110934858B (zh) 巴西木素作为α-突触核蛋白聚集抑制剂在制备药物、保健品或食品中的用途
Gawad et al. Effect of apitherapy on the pancreas and liver of streptozotacin induced diabetic rats: a biochemical and histological study
KR20090092267A (ko) 알레르기의 예방과 치료를 위한 약제의 제조에서 티모신 알파 1의 용도
Aizman et al. The combined treatment of Copaxone and Salirasib attenuates experimental autoimmune encephalomyelitis (EAE) in mice
CN106794218A (zh) 白细胞的细胞外诱捕网形成抑制剂
TW202340233A (zh) 肽用於治療神經退行性疾病或改善認知功能的用途
Ma et al. Ding Chuan Tang Attenuates Airway Inflammation and Eosinophil Infiltration in Ovalbumin‐Sensitized Asthmatic Mice
JP2006131622A (ja) 薬剤
HK1138513A (en) Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies
Wo et al. Treatment with human placental extracts inhibits allergic rhinitis by modulating AMPK/SHP1/SHP2/STING signaling
Liu et al. Blockage of IL-17 ameliorates Aβ-induced neurotoxicity and cognitive decline
Hung et al. Regulation of stromal cell-derived factor-1 and exhaled nitric oxide in asthmatic children following montelukast and ketotifen treatment
CN109771446A (zh) 唾液链球菌k12在制备预防和/或治疗自身免疫性疾病的药物中的应用
JP2010507650A (ja) 自己免疫疾患の予防及び治療用の薬剤を調製するためのチモシンアルファ１の使用
Elsayed The bioactive effect of royal jelly against histamine level induced by lysophosphatidic acid (LPA).
Greuel Potential chemical inhibitors of inflammasomes modulate microglial and astrocytic functions

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20090421

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid